Swiss giant UBS posts $770 million in net profit, launches $1 billion share buyback in first half

Swiss giant UBS posts 0 million in net profit, launches  billion share buyback in first half


Fabrice Coffrini | Afp | Getty Images

Swiss banking giant UBS on Tuesday posted $770 million in fourth-quarter net profit, launching a $1 billion share buyback program in the first half of 2025.

The net profit figure compares with a mean forecast of $886.4 million in a LSEG poll of analysts and with a $483 million estimate in a company-provided estimate.

After weathering the storm of a turbulent government-backed tie-up with fallen domestic rival Credit Suisse in 2023, UBS hoped to achieve $7.5 billion out of a total of $13 billion in cost savings by the end of last year, with CEO Sergio Ermotti signaling in a Bloomberg interview last month that redundancies were “inevitable” as part of the process — even as the group aims to rely on voluntary departures.

The Swiss belt tightening adds to a picture of broader expense discipline and restructuring across Europe’s banking sectors, as lenders exit a period of high interest rates and claw profitability to keep pace with U.S. peers. On Monday, fellow Swiss bank Julius Baer revealed an additional target of 110 million of Swiss francs ($120 million) in gross savings, while HSBC last week said it is preparing to wind down its M&A and equity capital markets operations in Europe, the U.K. and the U.S.

Armed with a balance sheet that topped $1.7 trillion in 2023 — roughly double Switzerland’s anticipated economic output last year — UBS has been battling vocal concerns at home that its scale has breached the Swiss government’s comfort, depriving the lender of peers that can absorb it and facing Bern with a steep nationalization price tag, in the event of its failure.

The Swiss economy has already been backed into a fragile corner by depressed annual inflation — of just 0.6% in December — and a punitively strong Swiss franc, which only gained further ground on Monday as the global tumult resulting from U.S. tariffs pushed jittery investors toward the safe-haven asset.

 This breaking news story is being updated.



Source

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More
Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’
Finance

Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’

Key Points Raymond James estimates that what consumers pay in higher gas prices could total exactly what they’re set to gain with the tax changes under President Donald Trump’s “big beautiful bill.” The stimulus was expected to boost both the U.S. economy and markets in 2026.  While consumers may not get as much of a […]

Read More
Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more

Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience […]

Read More